phase readout
saveNCT05479045: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
NOT_YET_RECRUITINGupdated 14d ago
community read0 votes
Sponsor: Georgetown University. Phase: PHASE2. Conditions: Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3
view source ↗
comments(0)
5-min edit window · permanent after that